Skip to main content

Month: May 2023

IPSOS: Monthly declaration of shares and voting rights – April 2023

May 31, 2023 MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Articles L. 233-8 II of the Commercial Code and 223-16 of the General Regulation of the AMFDate   Shares   Voting rightsTheoretical* Exercisable**30 April 2023 44,253,225 49,609,428 48,757,337*This number is calculated on the basis of all the shares to which voting rights are attached, including shares which voting rights have been suspended, in accordance with Article 223-11 of the AMF general regulation related to the calculation of the crossing of thresholds with regard to the number of voting rights. **For information purposes, this number excludes the shares which voting rights have been suspended. The information is also available in the « Regulated Information » section of the Ipsos website: https://www.ipsos.com/en/regulated-informations/en.  ...

Continue reading

Alvotech to Participate in Jefferies Healthcare Conference

REYKJAVIK, Iceland, May 31, 2023 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Jefferies Healthcare Conference in New York on June 7, 2023. Alvotech will present and host investor and business meetings at the conference. Anil Okay, Chief Commercial Officer is scheduled to give a presentation on June 7, 2023 at 4:30 pm EST. A webcast of the presentation will also be available and can be accessed in the Investors Section of Alvotech’s website under News and Events – Events and Presentations. After the event, a recording will be available for 90 days. About AlvotechAlvotech is a biotech company, founded by Robert Wessman, focused solely on the development and manufacture of...

Continue reading

Alvotech to Participate in Jefferies Healthcare Conference

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Jefferies Healthcare Conference in New York on June 7, 2023.  Alvotech will present and host investor and business meetings at the conference. Anil Okay, Chief Commercial Officer is scheduled to give a presentation on June 7, 2023 at 4:30 pm EST. A webcast of the presentation will also be available and can be accessed in the Investors Section of Alvotech’s website under News and Events – Events and Presentations. After the event, a recording will be available for 90 days. About AlvotechAlvotech is a biotech company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks...

Continue reading

Session, Germany’s trusted music retailer, chooses Agillic to drive personalisation and accelerate growth both online and off

Through Agillic’s flexible data model, dynamic headless content capabilities, and GDPR compliance, Session aims to create more targeted, seamless customer experiences both online and off. Since 1979, Session has been Germany’s trusted music retailer. With over 100 million views on YouTube, the largest music stores in Walldorf (Baden) and Frankfurt, a growing e-commerce site and a passion to make more music, session operates with one standard — Create the best shopping experience possible. With Agillic’s Omnichannel Marketing Automation Platform, session will provide new and existing customers with a more seamless and tailored experience, from the first purchase to practical advice on maintenance and care. Through Agillic’s communication channels, dynamic headless content capabilities, flexible data model and full GDPR compliance,...

Continue reading

Ensurge Micropower ASA to host a Q&A session with the new Chairman of the Board

Ensurge Micropower ASA (“Ensurge” or the “Company”) and SpareBank 1 Markets have the pleasure of inviting you to an introduction and Q&A session with the newly elected Chair of the Board of the Company, Terje Rogne, on Monday 5 June at 11:00 am CEST.  The presentation will take place in Microsoft Teams. To take part, please use the following link: https://teams.microsoft.com/dl/launcher/launcher.html?url=%2F_%23%2Fl%2Fmeetup-join%2F19%3Ameeting_ODQ3YTBjMWYtNjg0Yi00MGQ5LWJjMDAtMGFmMDYyZTNkYmJi%40thread.v2%2F0%3Fcontext%3D%257B%2522Tid%2522%253A%252210b30f00-1bbd-4041-9c4d-64749f4a7041%2522%252C%2522Oid%2522%253A%2522e3014d1b-0e14-4d70-83e6-a96d2e654403%2522%252C%2522IsBroadcastMeeting%2522%253Atrue%252C%2522role%2522%253A%2522a%2522%257D%26btype%3Da%26role%3Da%26anon%3Dtrue&type=meetup-join&deeplinkId=ed787b95-e49a-4d1d-af28-0070d06d0dcc&directDl=true&msLaunch=true&enableMobilePage=true&suppressPrompt=true Contact: Terje...

Continue reading

Notice of calling the annual general meeting of shareholders of AS Trigon Property Development

AS Trigon Property Development (registry code 10106774, address Pärnu mnt 18, Tallinn 10141, hereinafter the „Company“) calls the annual general meeting of Company’s shareholders, which shall be held at 10:00 on 21 June 2023 (here and hereafter Estonian time, GMT+3) at the Company’s office, at Pärnu mnt 18, Tallinn, 10141, IV floor. Registration for the meeting starts at 09:00 on the date of the meeting. Agenda of the meeting and the Management Board proposals for the draft resolutions to be adopted, which have been approved by the Supervisory Board:           1.     Approval of the annual report of the Company for the financial year 2022 To approve the annual report of the Company for the financial year 2022, in accordance with which the balance sheet value of the Company as at 31 December 2022 was 1,738,576 Euros and the net profit for...

Continue reading

European Energy A/S expresses confidence for another solid year with their Q1 report

Company announcement 8/2023 (31.05.2023) In the first quarter of 2023 several milestones have been achieved by European Energy, as the company passed 1 GW of owned assets, got an unprecedented number of renewable energy project permits and signed an agreement with Novo Nordisk and the LEGO Group to supply e-methanol to be used in some future plastic production.. Throughout the first quarter of 2023, European Energy has successfully ensured the roll-out of various renewable energy initiatives. One result was that the highest number of new project authorisations in a single quarter was secured. In three months, 1 GW of renewable energy permits has been secured across several key markets. At the same time, European Energy has successfully grid-connected 182 MW of projects during the quarter compared to 69 MW in Q1 22.  For the first six months...

Continue reading

Company announcement no 6/2023 – Interim Report Q1 2023

Interim Report Q1 2023 EBITDA fixed herd prices (FHP) for Q1 2023 increased to 5.935 mEUR (Q1 2022: 263 kEUR), corresponding to an EBITDA margin FHP of 18.1% (Q1 2022: 1.3%). The quarterly EBITDA in Q1 2023 increased by 5.672 kEUR (compared to Q1 2022).  Mainly driven by improved sales prices, as they in Q1 2023 were 1.51 EUR/kg live weight, up from 1.07 EUR/kg Q1 2022. Feed prices in Q1 2023 were 298 EUR/T (compared to 356 EUR/T Q4 2022). End Marts 2023 3.3 mEUR hedging gains are included in Group equity in other reserves, which will be released into EBITDA during next 6 months.  The herd valuation in Q1 increased by 6,418 kEUR (compared to 31.12.2022). The increase is driven by increasing price in EU, as the EU supply of pork has been reduced during the last 2-3 years. Net interest-bearing debt (NIBD) decreased to EUR 63.5m end Q1...

Continue reading

Kalmar introduces collision warning system for straddle carriers

Kalmar straddle carriers Kalmar straddle carriersKalmar straddle carriers Kalmar straddle carriersCARGOTEC CORPORATION, TRADE PRESS RELEASE, 31 MAY 2023 AT 10 AM (EEST) Kalmar, part of Cargotec, is introducing a collision warning system for its manually operated straddle carrier portfolio as part of the company’s commitment to safety-first design. The system is available as an optional add-on for new machines and a retrofit upgrade for existing machines. It increases safety by providing the driver with both visible and audible warnings when there is a risk of collision, giving them more time to react to potential hazards.   These timely warnings help to prevent or reduce the severity of collisions and also reduce stress on the driver by helping them to remain alert and attentive at all times. In addition to detecting obstacles...

Continue reading

Matas Group Annual Report 2022/23

Company announcement no. 2 2023/24Allerød, 31 May 2023Matas Group Annual Report 2022/23A strong finish to a year of progress and growthMatas Group generated total revenue of DKK 4,490 million for the financial year 2022/23, a year-on-year increase of 3.3% from DKK 4,344 million in 2021/22. Growth in the fourth quarter came to 8.3%. EBITDA before special items rose to DKK 809 million (18.0%) from DKK 803 million in 2021/22 (18.5%). Profit before tax amounted to DKK 373 million, an increase of DKK 22 million from DKK 351 million in 2021/22. For the financial year 2023/24, organic revenue is expected to grow between 3% and 6%. The EBITDA margin before special items is expected around 17%. Investments, excluding M&A, are expected in the DKK 425-450 million range, including approximately DKK 250 million for the Matas Logistics Center. Matas...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.